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Abstract
Introduction: Acute cough has a significant impact on physical and psychosocial health and is associated with an
impaired quality of life (QOL). The Leicester Cough Questionnaire (LCQ) is a validated cough-related health status
questionnaire designed for patients with chronic cough. The purpose of this study was to validate the LCQ for the
assessment of health related QOL in patients with acute cough and determine the clinical minimal important
difference (MID).
Methods: 10 subjects with cough due to acute upper respiratory tract infection underwent focused interviews to
investigate the face validity of the LCQ. The LCQ was also evaluated by a multidisciplinary team. 30 subjects
completed the revised LCQ-acute and a cough visual analogue score (VAS: 0-100 mm) within one week of onset of
cough and again <2 weeks later and at resolution of cough. The concurrent validity, internal reliability, repeatability
and responsiveness of the LCQ-acute were also assessed. Patients also completed a Global Rating of Change
Questionnaire that assessed the change in cough severity between visits. The MID was calculated as the change in
LCQ-acute score for patients responding to GRCQ category representing the smallest change in health status that
patients found worthwhile.
Results: Health status was severely impaired at baseline affecting all domains; median (interquartile range) total
LCQ-acute score 13.0 (3.4). All subjects found the LCQ-acute questionnaire acceptable for assessing their cough.
Internal reliability of the LCQ-acute was good for all domains and total score, Cronbach’s a coefficients >0.9. There
was a significant correlation between LCQ-acute and VAS (r = -0.48, p = 0.007). The LCQ-acute and its domains
were highly responsive to change; effect sizes 1.7-2.3. The MID for total LCQ and VAS were 2.5 and 13 mm
respectively.
Conclusion: The LCQ-acute is a brief, simple and valid instrument to assess cough specific health related QOL in
patients with acute cough. It is a highly responsive tool suggesting that it will be particularly useful to assess the
effect of antitussive therapy.
Introduction
Acute cough impacts significantly on physical and psy-
chosocial health, leading to impairment in quality of life
(QOL) [1]. Chest pain, nausea and sleep disturbance are
particularly common [2]. Twenty million work days are
lost each year in the USA due to acute cough according
to the National Centre for Health Statistics [3]. The
assessment of cough severity in acute cough is limited to
self reported symptom scales, scores or diaries. There is
increasing recognition that health related quality of life
assessment is important, particularly in the evaluation of
therapy. We have previously reported the development
and validation of the Leicester Cough Questionnaire
(LCQ) which is a brief, self completed, widely used,
health related QOL questionnaire for chronic cough [4].
It is not known if the LCQ could be used to assess QOL
in acute cough. The aim of this study was to adapt, vali-
date and assess the LCQ for patients with acute cough
and to determine the minimal important difference
(MID).
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Subjects
30 subjects (10 men) with cough due to acute upper
respiratory tract infection were recruited within one week
of onset of symptoms. Patients were recruited during the
peak cough/cold season October to April. An upper
respiratory tract infection was considered a cause of acute
cough if subjects had 2 or more symptoms at least 1 day
prior to the study of: rhinorrhoea, sneezing, fever, myalgia,
malaise, headache and sore throat [5]. Subjects with a his-
tory of respiratory disease, chronic cough or those taking
antitussive or upper respiratory tract infection drugs or
angiotensin converting enzyme inhibitors were excluded. 1
patient had a history of seasonal allergic rhinitis. Informed
consent was obtained from all patients and the study was
approved by the local research ethics committee.
Questionnaires
Leicester Cough Questionnaire (LCQ)
The LCQ is a 19 item questionnaire that assesses cough-
related QOL [4]. It has 3 domains (physical, psychological
and social). The total score range is 3-21 and domain
scores range from 1-7; a higher score indicates a better
quality of life. The questionnaire was revised so that each
item related to the patient’s experience within a 24 hour
time frame (see Additional File 1).
Cough Visual Analogue Scale (VAS)
T h ec o u g hV A Si sa1 0 0m ms c a l eo nw h i c hp a t i e n t s
indicate the severity of cough [6].
Global Rating of Change Questionnaire (GRCQ)
The GRCQ is a 15 point scale widely used to determine
the MID of health related QOL questionnaires [7].
Patients were asked to rate global changes in health and
sub-domains using 4 GRCQs. The GRCQ response ranged
from -7 (a great deal worse) to +7 (a great deal better) and
was classified as unchanged (-1,0,+1), small change (-3,-2,
+3,+2), moderate change (-5, -4, +5, +4) and large change
(-7, -6, +7, +6). MID was defined as the change in LCQ
score corresponding to a small change in GRCQ score.
Protocol
The LCQ and VAS were completed on three occasions.
Patients completed the LCQ-1, VAS-1 and a structured
questionnaire designed to record demographics and
symptoms associated with acute cough within one week
of onset. Patients were asked to complete a GRCQ and
a repeat LCQ-2 and VAS-2 within 2 weeks of LCQ-1
and again when the cough resolved (LCQ-3 and VAS-3.)
Validation
1. Face Validity
The suitability of the wording and content of the LCQ
for detecting health related QOL in patients with acute
cough was assessed by:
a. A literature review of QOL assessment in acute
cough.
b. Review of the LCQ by a multidisciplinary team
(doctor, nurse, physiotherapist, pharmacist)
c. Focussed interviews with 10 patients with acute
cough to assess its impact on QOL and to ascertain
their views on the suitability of the LCQ to assess
QOL.
2. Concurrent Validity
Concurrent validity is the assessment of an instrument
against other standards; it was assessed by correlating
LCQ-1 scores with cough VAS-1.
3. Internal Reliability
Internal reliability of each domain was assessed by
determining Cronbach’s alpha coefficients which indi-
cate the extent to which items are related. Internal relia-
bility is generally acceptable if Cronbach’sa l p h a
coefficient is greater than 0.7.
4. Repeatability
The repeatability of the LCQ was assessed in those
patients indicating no change in health status on the
GRCQ over 2 weeks.
5. Responsiveness
The responsiveness of the LCQ and VAS was deter-
mined by calculating the effect size of change between
baseline and resolution of the cough.
6. Minimal Important Difference
The MID of the LCQ and VAS were determined using
anchor based methods using the GRCQ as described by
Juniper [7].
Statistical Analysis
SPSS version 16 was used for data analysis. Data are
presented as mean (standard error of the mean or stan-
dard deviation) or median (inter-quartile range) accord-
ing to its distribution. In accordance with previous
studies we expressed global rating scores as absolute
numbers i.e. when the change was negative, the sign
w a sr e v e r s e da sw a st h es i g no fc h a n g ei nL C Qs c o r e
[8]. Spearman’s correlation coefficient was used to deter-
mine concurrent validity. Mann Whitney tests were used
to compare groups. Internal reliability was tested by
determining Cronbach’s alpha coefficient. Repeatability
was assessed by determining the intra class correlation
coefficients.
Results
All patients that were interviewed found the LCQ suita-
ble for use in acute cough. The only modification to the
LCQ after review by the multidisciplinary meeting was
alteration of the time frame for each item from 2 weeks
to the past 24 hours. See Additional File 1 for the final
version of LCQ-acute. 2 patients did not complete the
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of the MID. Subject characteristics are given in table 1.
Health related QOL was impaired at baseline; median
(IQR) total LCQ score 12.8 (3.4), physical 4.5 (1.1), psy-
chological 4.9 (1.1) and social 4 (1.4). There were no sig-
nificant gender differences in VAS, LCQ or GRCQ
scores.
There was a significant correlation between the cough
VAS and the LCQ total score at baseline (r =- 0 . 4 8 ,p=
0.007; figure 1). Internal consistency was high for all
domains and total LCQ score (table 2). Only 4 patients
indicated a GRCQ score of 0, 2 patients indicated a
G R C Qs c o r eo f1 ;t h i ss a m p l es i z ew a sc o n s i d e r e dt o o
small to determine intraclass coefficient of repeatability.
QOL improved between visits 1 and 2; median LCQ
score 12.8 vs 16.7; p <0.001. QOL improved in all but
one patient between visits 1 and 2. The median change in
LCQ score for each GRCQ category is given in table 3.
The LCQ MID corresponding to a small change in the
GRCQ was 2.5 (table 3). The correlation between GRCQ
score and change in LCQ total was r = 0.6 (p = 0.001)
and for domains: physical r = 0.51 (p = 0.05), psychologi-
cal r = 0.46 (p = 0.02) and social r = 0.47 (p = 0.01). The
LCQ and VAS were responsive to reductions in cough
severity (table 4). There was a weak relationship between
change in VAS score and change in LCQ score (r = 0.37,
p = 0.05). The MID for VAS was 13 mm. There was no
correlation between change in VAS and GRCQ score (r =
0.02, p = 0.78).
Discussion
The LCQ-acute is a valid health status measure for
patients with acute cough. It is easy to use, self adminis-
tered and takes less than 5 minutes to complete. The
LCQ-acute was highly responsive to change, suggesting it
might be particularly useful in assessing the response to
treatment both in clinic and in clinical trials. The mini-
mal important difference, the smallest change in health
status patients find worthwhile was a change in LCQ-
acute score of 2.5.
We validated the LCQ-acute for acute cough using a
well accepted QOL instrument development methodology
[9]. The only alteration to the original LCQ was a reduc-
tion in the assessment period from 2 weeks to 24 hours to
reflect the rapid change in symptoms associated with
acute cough. The validity of the LCQ-acute was compar-
able to the original LCQ used by patients with chronic
cough; face and concurrent validity, internal reliability and
responsiveness were within acceptable standards for qual-
ity of life questionnaires [9]. We were unable to determine
the repeatability of the LCQ-acute since most patients
reported improvement in cough severity within the time
frame of this study. A shorter time interval between test
and retest questionnaires or a much larger study may
allow the determination of repeatability coefficients in
future. It is possible that symptoms of upper respiratory
tract infection other than cough may have influenced qual-
ity of life. The LCQ-acute questionnaire items were how-
ever individually phrased to be relevant to cough.
Table 1 Subject characteristics (n = 30)
Characteristic
Age mean (SD) 32 (10)
Male n (%) 10 (33)
Smokers n (%) 2 (7)
Non smokers n (%) 28(93)
Duration of cough in days (SD) 12 (9)
LCQ score baseline median(IQR) all patients 12.8 (14.9; 11.5)
LCQ score baseline median (IQR) females 13.5 (15.8; 11.2)
LCQ score baseline median (IQR) males 13.4 (16.5; 10.3)
VAS score baseline mean(SD)mm all patients 39 (25)
VAS score baseline mean(SD)mm females 39 (26)
VAS score baseline mean(SD)mm males 37 (23)
Tiredness n (%) 24 (80%)
Sore throat 18 (60)
Runny nose 17 (57)
Sneezing 16 (53)
Headache 16 (53)
Clear sputum 14 (47)
Coloured sputum 14 (47)
Aches/pains 12 (40)
Fever 10 (33)
Facial pain 9 (30)
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Figure 1
Table 2 Internal consistency reliability (Cronbach’s Alpha
coefficients)
LCQ Cronbach’s Alpha Coefficient
Total 0.94
Social 0.90
Psychological 0.90
Physical 0.95
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the interpretation of health status data from clinical stu-
dies and calculate sample sizes for future studies. The
MID was greater than that for patients with chronic
cough (1.3) [8]. This may be due to small changes in
quality of life having a larger impact in chronic condi-
tions due to the cumulative effect of living with the
symptom for many years. We chose anchor based metho-
dology to determine the MID rather than distribution
methods based on standard deviations since the latter
depend on the heterogeneity of the population under
study and utilises arbitrary units of measure [10-12].
There are limitations with the anchor based methodol-
ogy. We included patients with GRCQ scores +/- 1 in the
“unchanged” category and it is therefore possible that
some patients may have experienced a significant change
in cough. We chose this method to be consistent with
those described by Juniper; [7] moreover, they have pre-
viously reported that a GRCQ score of +/- 1 does not
represent clinically significant change. The GRCQ is a
subjective instrument and subject to recall bias. Our find-
ings need confirmation with objective assessment of
cough severity such as cough reflex sensitivity measure-
ment and cough monitoring. The time-frame for GRCQ
was relatively short and this may have minimised the
effect of recall bias. The determination of the MID by
prospective methodology avoids some of the limitations
of the anchor based methods; this deserves consideration
in future studies (Irwin RS, personal communication and
data in press). We found a significant correlation
between GRCQ and the change in LCQ-acute scores
supporting the use of the GRCQ. There was a step-wise
increase in change in LCQ-acute scores across GRCQ
categories, which suggests that LCQ-acute can discrimi-
nate patients with small and large changes in health sta-
tus. Our study demonstrates that health status improves
in the vast majority of patients with acute cough. Further
studies will be needed to determine if a MID of 2.5 is
applicable for patients whose health status deteriorates.
We were unable to perform a subanalysis to determine
whether the MID varied according to age, gender or
strain of virus; this will require further investigation. We
determined the LCQ-acute MID in a natural recovery
study design. It may be difficult to establish the MID in
patients taking currently available antitussive drugs since
the relative improvement in cough severity due to natural
recovery, placebo effect and therapeutic effect of the anti-
tussive drug are not clear. We suggest that antitussive
drugs should aim to achieve a clinical benefit that is
greater than an increase of LCQ-acute score of at least
2.5 units. This should ideally be achieved at an earlier
phase of the illness.
The impairment in quality of life suffered by our
cohort of subjects with acute cough was comparable to
that of chronic cough [13]. The impairment in QOL
was moderate to severe but transient compared to
chronic cough. All health domains were affected. A sig-
nificant impairment in the health status of patients with
acute cough was also found in a study using the CQLQ,
another validated cough specific health status question-
naire for patients with acute and chronic cough [1].
Although this seems surprising for such a common and
benign condition, it reflects the fact that the LCQ-acute
and CQLQ are cough specific health measures. It is
likely that general health related QOL determined by
generic tools such as the SF36 will demonstrate a lesser
impact on QOL in acute compared with chronic cough.
This is the first study to validate the cough VAS in
subjects with acute cough and determine its MID. The
VAS is easier to use and widely recognised compared to
QOL tools. QOL tools however have the advantage that
they quantify overall health status and identify the sub-
domains of health affected. The relationship between
Table 3 Change in Leicester cough questionnaire score and visual analogue score per global rating of change
category
Global rating of change questionnaire categories
Unchanged (-1/0/1) Small (-3/-2/2/3) Moderate (-5/-4/4/5) Large (-7/-6/6/7)
Change in LCQ total score N = 6 1.2 (0.9) N = 12 2.5 (3.1) N = 6 4.6 (2.9) N = 4 6.8 (3.5)
Change in LCQ physical score N = 1 (0.6) N = 14 0.6 (0.8) N = 8 1.0 (0.8) N = 5 1.9 (1.5)
Change in LCQ psychological score N = 9 0.1 (1.0) N = 8 0.7 (1.2) N = 7 1.4 (0.9) N = 4 2.2 (1.5)
Change in LCQ social score N = 6 0.6 (0.4) N = 14 0.9(1.4) N = 5 2.3 (0.3) N = 3 2.5 (0.6)
Change in cough VAS score (mm) * N = 6 7.0 (0.6) N = 12 13.0 (0.6) N = 6 13.0 (0.6) N = 4 33.0 (2.3)
N = number of cases. Median (interquartile range) except * mean (standard deviation).
Table 4 Responsiveness of LCQ-acute: Effect sizes
Effect size
LCQ Total 2.3
LCQ Social 1.7
LCQ Psychological 1.8
LCQ Physical 2.3
VAS 1.4
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with chronic cough and there was no relationship
between the global health assessment tools (GRCQ) and
VAS in contrast to the LCQ-acute. This suggests that
VAS cannot be used as a substitute for health related
QOL tools. Furthermore, we have demonstrated that the
LCQ-acute is more responsive to changes in cough
severity than the VAS.
In conclusion, there are a range of options available to
assess cough severity in acute cough. The LCQ-acute
should be used to complement other subjective tools
and objective tools such as cough reflex sensitivity and
ambulatory cough frequency monitoring. The LCQ-
acute represents an advance in the assessment of cough
severity and should aid clinicians and researchers in
making meaningful interpretations of health related
QOL outcomes.
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